A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Healthy Subjects
Clinical trial NCT03958864 · COMPLETED
Trial details
- NCT number
- NCT03958864
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-04
- Primary completion
- 2019-06-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.